Corporate Law · October 2025
Raising Capital for Your Wellness Brand: A Legal Roadmap
Health and wellness brands are attracting significant investor interest. We map out what you need to get right before you raise.
Wellness is one of the most active consumer-investment categories in the private market. Functional beverages, supplements, medspa chains, fitness concepts, and digital wellness platforms are all drawing institutional and family-office capital. For founders, the opportunity is real. But the mechanics of raising capital are governed by federal and state securities laws that do not bend for the quality of the product or the passion of the founder. Getting the legal roadmap right before the first outside dollar comes in is the difference between a clean cap table at Series A and a costly cleanup later.
Start with the entity and the cap table
Almost every institutional wellness investor expects a Delaware C-Corp. LLCs and S-Corps create tax and structural problems that investors either will not accept or will force conversion on at a bad time. The cap table needs to be clean: founder equity properly issued with vesting, 83(b) elections filed within thirty days of issuance, IP assignments in place, and an equity incentive plan authorized and documented. Founders who skip these foundational steps typically pay to fix them during the first diligence process, which is the worst possible leverage moment.
Friends-and-family rounds are securities offerings
The $50,000 check from a family friend is not informal. It is a securities sale, and it must comply with a registration exemption — most commonly Rule 506(b) of Regulation D. That exemption allows up to thirty-five non-accredited purchasers who receive appropriate disclosure, no general solicitation, and a Form D filing with the SEC within fifteen days of first sale, plus state notice filings. Skipping these steps does not make the round informal; it makes it noncompliant, which gives every investor a rescission right — the ability to demand their money back with interest — for up to a year or more after the fact.
SAFEs and convertible notes are the early-stage standard
Most seed-stage wellness raises use SAFEs (Simple Agreements for Future Equity) or convertible notes. Both convert to equity at a future priced round, typically at a valuation cap and/or a discount. The terms that matter most are the valuation cap (which determines how much of the company the early investor effectively owns), the discount rate, the conversion triggers, and the handling of acquisitions before a priced round. Most-favored-nation provisions, pro-rata rights, and information rights are secondary but shape the follow-on round dynamics.
Regulatory overlays specific to wellness
Wellness businesses often sit across multiple regulatory regimes. FDA and FTC rules govern health claims, structure-function claims, and substantiation requirements. State regulators oversee supplement manufacturing and telehealth arrangements. Medical-aesthetic and medspa businesses may be subject to corporate-practice-of-medicine limitations. Investors will diligence these issues, and gaps here are often more disqualifying than financial performance. Building the regulatory file alongside the investment file pays off in faster diligence and a higher close rate.
Priced rounds change the governance conversation
When a wellness company moves to a priced preferred round — typically Series Seed or Series A — the term sheet introduces preferred stock with a liquidation preference, board composition changes, protective provisions (investor veto rights over specified corporate actions), information rights, and anti-dilution provisions. Each of these has standard-range terms and investor-favorable terms. A term sheet that looks reasonable on the economic terms can have governance terms that make the company harder to run and harder to exit. Founders need counsel who has seen enough of these to identify where a term sheet is standard and where it is pushing beyond market.
Ongoing obligations do not end at closing
Post-closing, the company owes its investors information rights, compliance with protective provisions, 409A valuations before any subsequent option grants, and Blue Sky filings in states where investors reside. These obligations are not optional, and missing them is the kind of background noise that surfaces during the next round's diligence. Building an investor-relations and compliance cadence at the first close is much easier than reconstructing the record two years later.
The wellness brands that raise successfully and keep their cap tables clean are the ones that treat the legal roadmap as part of the fundraising plan — not something to figure out after the money is in. The legal work done before the first close is cheaper, cleaner, and more strategically useful than the same work done in a diligence room.
Continue Reading
Related Legal Counsel
More Insights
Other Articles
Have a Related Matter?
Schedule a consultation with Shah Grossi. We respond within one business day.